Related Experiment Video
Updated: Apr 8, 2026

Programmed Electrical Stimulation in Mice
Published on: May 26, 2010
Prolonged action potential duration in cardiac ablation of PDK1 mice
Zhonglin Han1, Yu Jiang1, Zhongzhou Yang2
1Department of Cardiology, The First Affiliated Hospital, Nanjing Medical University Nanjing, China.
Abstract:
The involvement of the AGC protein kinase family in regulating arrhythmia has drawn considerable attention, but the underlying mechanisms are still not clear. The aim of this study is to explore the role of 3-phosphoinositide-dependent protein kinase-1 (PDK1), one of upstream protein kinases of the AGC protein kinase family, in the pathogenesis of dysregulated electrophysiological basis. PDK1(F/F) αMHC-Cre mice and PDK1(F/F) mice were divided into experiment group and control group. Using patch clamping technology, we explored action potential duration in both groups, and investigated the functions of transient outward potassium channel and L-type Ca(2+) channel to explain the abnormal action potential duration. Significant prolongation action potential duration was found in mice with PDK1 deletion. Further, the peak current of transient outward potassium current and L-type Ca(2+) current were decreased by 84% and 49% respectively. In addition, dysregulation of channel kinetics lead to action potential duration prolongation further. In conclusion, we have demonstrated that PDK1 participates in action potential prolongation in cardiac ablation of PDK1 mice. This effect is likely to be mediated largely through downregulation of transient outward potassium current. These findings indicate the modulation of the PDK1 pathway could provide a new mechanism for abnormal electrophysiological basis.
Insights
3-phosphoinositide-dependent protein kinase-1 (PDK1) deletion prolongs cardiac action potential duration by reducing potassium and calcium channel currents. This highlights PDK1
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Cardiac Electrophysiology
Background:
- The AGC protein kinase family regulates cardiac function, but its upstream mechanisms, particularly involving 3-phosphoinositide-dependent protein kinase-1 (PDK1), remain unclear.
- Dysregulation of cardiac electrophysiology underlies arrhythmias, necessitating a deeper understanding of molecular regulators like PDK1.
Purpose of the Study:
- To investigate the role of PDK1 in the pathogenesis of cardiac electrophysiological abnormalities.
- To elucidate the impact of PDK1 deletion on action potential duration and ion channel function in the heart.
Main Methods:
- Utilized PDK1(F/F) αMHC-Cre and PDK1(F/F) mice models for experimental and control groups.
- Employed patch-clamp technology to measure action potential duration and ion channel currents.
- Analyzed the function of transient outward potassium (Ito) and L-type Ca2+ (ICaL) channels.
Main Results:
- PDK1 deletion in mice resulted in significant prolongation of action potential duration.
- A marked decrease in peak Ito (84%) and ICaL (49%) currents was observed in PDK1-deficient hearts.
- Altered ion channel kinetics contributed to the prolonged action potential duration.
Conclusions:
- PDK1 plays a crucial role in regulating cardiac action potential duration.
- PDK1 deficiency leads to prolonged action potential duration, primarily mediated by the downregulation of transient outward potassium current.
- Targeting the PDK1 pathway may offer a novel therapeutic strategy for managing abnormal cardiac electrophysiology.

